Connect with us


AMERICAN LIVES FIRST: Trump U-Turns On Decision To Wind-Down Virus Task Force – “It Will Remain Indefinitely”

PRESIDENT Donald Trump has reassured Americans that – after rising concerns – the White House’s coronavirus task force will continue on “indefinitely” — rightly reversing his statement on Tuesday that it was “winding down.”

The President tweeted that the task force will now have a new focus on safety, reopening the economy, and vaccines. 

The task force, led by Vice President Mike Pence, has effectively guided and come to the aid of American citizens since the outbreak began, with Trump acknowledging this again, saying:

“They’ve done a fantastic job of bringing together vast highly complex resources that have set a high standard for others to follow in the future.

“Because of its efforts, ventilators are being made “in the thousands, and we have many to spare

“We are helping other countries which are desperate for them. Likewise, after having been left little, we are now doing more testing than all other countries combined, and with superior tests.

“Because of this success, the Task Force will continue on indefinitely with its focus on safety and opening up our country again.”

According to Trump, the task force will be changing its approach to “also be very focused on Vaccines & Therapeutics” – with opponents raising concerns that the approach may simply be an appeasement of critics objecting to the task force’s disbandment while using the force to essentially achieve its main focus – to reopen the economy.

Trump told reporters on Tuesday while touring a Honeywell mask manufacturing plant: “We will have something in a different form.”

“I think we’re looking at phase two and we’re looking at other phases… the task force has done a phenomenal job.”

“Nobody has done the job we have done,” he added. “Does anybody really believe we have less cases than China?”

Written By


Schengen Visa – Europe Short Stay Visa Types and Application


Back in the New Year


Want To Solve The NHS’s Woes? Get Patients To Use New Technology